Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

Ucar G., Acikgoz Y., Ergun Y., Bal O., Yilmaz M., Karakaya S., ...More

CUREUS, vol.12, no.9, 2020 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 9
  • Publication Date: 2020
  • Doi Number: 10.7759/cureus.10525
  • Journal Name: CUREUS
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Directory of Open Access Journals
  • Keywords: renal cell carcinoma, metastasis, sunitinib, pazopanib, nivolumab, TRIALS
  • Marmara University Affiliated: No

Abstract

Introduction